HuaTeng Biotechnology provides high-fidelity Carotid Artery Balloon Injury models in porcine, rabbit, and rat. Fully compliant with OECD GLP and AAALAC standards for evaluating DCB, stents, and anti-restenosis therapeutics.
Indication / Application
Cardiovascular interventional validation (e.g., Drug-Coated Balloons / DCB, Drug-Eluting Stents / DES), anti-restenosis pharmacological screening, and vascular neointimal hyperplasia mechanisms.
Modeling Method
Under fluoroscopic guidance or high-magnification microsurgery, a balloon catheter is introduced into the common carotid artery, inflated to a calibrated pressure, and retracted repeatedly to achieve uniform endothelial denudation and mechanical vessel wall injury.
Clinical Relevance
Translational Remodeling: Porcine and rabbit carotid arteries closely mirror human clinical vascular responses to mechanical trauma. Mechanical stretching via balloon inflation triggers a synchronized cascade of vascular smooth muscle cell (VSMC) proliferation and migration, accurately simulating human post-angioplasty restenosis.
Anatomical & Hemodynamic Fidelity: The luminal diameter, wall shear stress, and compliance of porcine carotid arteries provide a clinically relevant testing platform for human-scale interventional devices (such as DCBs and stents), ensuring high-fidelity translational data for global regulatory submissions (FDA, NMPA, CE).
Key Evaluation Endpoints
In Vivo / Surgical / Imaging:
Histopathology:
Molecular:
Regulatory-Grade Data Package (OECD GLP, AAALAC, CMA, CNAS): As an established preclinical CRO, all cardiovascular studies at HuaTeng Biotechnology are conducted under stringent global quality guidelines. Our highly experienced surgical team utilizes standardized inflation-pressure protocols to minimize operator-dependent variability, delivering ultra-consistent Intima/Media (I/M) expansion profiles designed to withstand rigorous regulatory audits for global IND and medical device registrants.